147 related articles for article (PubMed ID: 2424341)
1. Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes.
Levy JH; Zaidan JR; Faraj B
Anesth Analg; 1986 Jul; 65(7):739-42. PubMed ID: 2424341
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of patients at risk for protamine reactions.
Levy JH; Schwieger IM; Zaidan JR; Faraj BA; Weintraub WS
J Thorac Cardiovasc Surg; 1989 Aug; 98(2):200-4. PubMed ID: 2755152
[TBL] [Abstract][Full Text] [Related]
3. Anaphylactoid reactions to protamine: an often lethal complication in insulin-dependent diabetic patients undergoing vascular surgery.
Gupta SK; Veith FJ; Ascer E; Wengerter KR; Franco C; Amar D; el-Gaweet ES; Gupta A
J Vasc Surg; 1989 Feb; 9(2):342-50. PubMed ID: 2645443
[TBL] [Abstract][Full Text] [Related]
4. Adverse reactions to protamine sulfate during cardiac surgery in diabetic and non-diabetic patients.
Gottschlich GM; Gravlee GP; Georgitis JW
Ann Allergy; 1988 Oct; 61(4):277-81. PubMed ID: 3177970
[TBL] [Abstract][Full Text] [Related]
5. [A case of anaphylactic shock in an elderly man following protamine sulfate administration during emergent off-pump coronary artery bypass grafting].
Kudoh O; Warabi K; Yamaguchi K; Ichinose M; Iizuka T; Inada E
Masui; 2006 May; 55(5):605-10. PubMed ID: 16715917
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of preventing hypotension with H1/H2 antagonists before protamine administration].
Behne M; Bremerich D; Schiesser S; Asskali F
Infusionsther Transfusionsmed; 1994 Apr; 21(2):81-5. PubMed ID: 7517238
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization.
Stewart WJ; McSweeney SM; Kellett MA; Faxon DP; Ryan TJ
Circulation; 1984 Nov; 70(5):788-92. PubMed ID: 6488493
[TBL] [Abstract][Full Text] [Related]
8. Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine.
Weiss ME; Nyhan D; Peng ZK; Horrow JC; Lowenstein E; Hirshman C; Adkinson NF
N Engl J Med; 1989 Apr; 320(14):886-92. PubMed ID: 2648147
[TBL] [Abstract][Full Text] [Related]
9. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin.
Blanco C; Castillo R; Quiralte J; Delgado J; García I; de Pablos P; Carrillo T
Allergy; 1996 Jun; 51(6):421-4. PubMed ID: 8837667
[TBL] [Abstract][Full Text] [Related]
10. Allergic shock and death associated with protamine administration in a diabetic patient.
Chu YQ; Cai LJ; Jiang DC; Jia D; Yan SY; Wang YQ
Clin Ther; 2010 Sep; 32(10):1729-32. PubMed ID: 21194595
[TBL] [Abstract][Full Text] [Related]
11. Protamine allergy reactions during cardiac catheterization and cardiac surgery: risk in patients taking protamine-insulin preparations.
Vincent GM; Janowski M; Menlove R
Cathet Cardiovasc Diagn; 1991 Jul; 23(3):164-8. PubMed ID: 1831070
[TBL] [Abstract][Full Text] [Related]
12. Antibody formation after drug administration during cardiac surgery: parameters for aprotinin use.
Levy JH
J Heart Lung Transplant; 1993; 12(1 Pt 1):S26-33. PubMed ID: 7680234
[TBL] [Abstract][Full Text] [Related]
13. Fatal anaphylactic reaction to protamine after femoropopliteal by-pass surgery.
Hakala T; Suojaranta-Ylinen R
Ann Chir Gynaecol; 2000; 89(2):150-2. PubMed ID: 10905682
[TBL] [Abstract][Full Text] [Related]
14. Administration of clemastine--H1 histamine receptor blocker in the prevention of haemodynamic disorders after protamine sulfate administration in patients subjected to coronary artery bypass grafting in extracorporeal circulation.
Lango R; Mroziński P; Wujtewicz M; Suchorzewska J; Rogowski J; Narkiewicz M; Siebert J
Med Sci Monit; 2000; 6(4):769-75. PubMed ID: 11208407
[TBL] [Abstract][Full Text] [Related]
15. Serial immunological investigations in a patient who had a life-threatening reaction to intravenous protamine.
Weiss ME; Chatham F; Kagey-Sobotka A; Adkinson NF
Clin Exp Allergy; 1990 Nov; 20(6):713-20. PubMed ID: 1707334
[TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
[TBL] [Abstract][Full Text] [Related]
17. [Complications caused by protamine. 2. Therapy and prevention].
Hobbhahn J; Habazettl H; Conzen P; Peter K
Anaesthesist; 1991 Aug; 40(8):421-8. PubMed ID: 1952034
[TBL] [Abstract][Full Text] [Related]
18. [Complications caused by protamine. 1: Pharmacology and pathophysiology].
Hobbhahn J; Habazettl H; Conzen P; Peter K
Anaesthesist; 1991 Jul; 40(7):365-74. PubMed ID: 1928709
[TBL] [Abstract][Full Text] [Related]
19. Protamine-induced fatal anaphylaxis. Prevalence of antiprotamine immunoglobulin E antibody.
Sharath MD; Metzger WJ; Richerson HB; Scupham RK; Meng RL; Ginsberg BH; Weiler JM
J Thorac Cardiovasc Surg; 1985 Jul; 90(1):86-90. PubMed ID: 3892171
[TBL] [Abstract][Full Text] [Related]
20. Anaphylactic shock following protamine administration.
Vontz FK; Puestow EC; Cahill DJ
Am Surg; 1982 Oct; 48(10):549-51. PubMed ID: 7137721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
